13F filer · CIK 1603466 ↗
Point72
You are looking at Q4 2020. See the latest, Q2 2026 →
Reported value
$20.50B
+5.0% on the quarter before
Positions
878
366 new · 383 sold out
Top 10
15.4%
of the value
Est. gain
+$1.77B
on stocks held all quarter
Est. return
+20.2%
on those stocks since Q3 2020
Positions as of Dec 31, 2020, from Point72's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 26% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2020. Striped tiles are options.
Largest buys
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alphabet~$266.5MAdded · 1.5% → 3.0%+152,029 shares
- AMD~$223.8MAdded · 0.6% → 1.7%+2,440,596 shares
- Uber~$201.0MNew · 0.0% → 1.0%+3,940,267 shares
- Visa Inc.~$198.4MAdded · 0.4% → 1.4%+907,284 shares
- SPDR Ser TrPUT~$197.1MNew · 0.0% → 1.0%+1,400,000 underlying
- Astrazeneca Plc~$187.7MAdded · 0.1% → 1.0%+3,753,816 shares
- Twitter Inc~$143.8MAdded · 0.2% → 0.9%+2,656,480 shares
- Bristol-Myers Squibb CoCALL~$124.1MNew · 0.0% → 0.6%+2,000,000 underlying
- Microchip Technology~$112.3MAdded · 0.1% → 0.7%+813,075 shares
- Mastercard~$105.8MNew · 0.0% → 0.5%+296,414 shares
Largest sells
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alibaba~$413.4MSold out · 2.1% → 0.0%−1,406,261 shares
- Amazon~$359.8MCut · 2.5% → 0.7%−110,480 shares
- Palantir~$284.1MSold out · 1.5% → 0.0%−29,904,230 shares
- PayPal~$225.8MCut · 1.1% → 0.1%−963,941 shares
- Alexion Pharmaceuticals Inc~$182.3MCut · 0.8% → 0.2%−1,166,848 shares
- Haemonetics Corp~$164.6MCut · 0.7% → 0.2%−1,386,137 shares
- Qorvo~$157.8MCut · 0.6% → 0.0%−948,713 shares
- Csx Corp~$143.9MCut · 0.7% → 0.1%−1,585,854 shares
- Invesco Qqq TrPUT~$138.9MSold out · 0.7% → 0.0%−500,000 underlying
- Fiserv Inc~$126.7MCut · 1.1% → 0.5%−1,112,748 shares
Holdings
As of Dec 31, 2020. Changes are in shares against Sep 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AlphabetCAP STK CL A · shares +75% · price +19.6% | 3.0% | $623.7M | +$58.5M | ||||||||
| SPDR S&P 500 ETF TrPUTTR UNIT · shares −15% | 2.7% | $559.0M | — | ||||||||
| AMDCOM · shares +184% · price +11.9% | 1.7% | $345.3M | +$12.9M | ||||||||
| MetaCL A · shares +35% · price +4.3% | 1.5% | $309.5M | +$9.5M | ||||||||
| Visa Inc.COM CL A · shares +240% · price +9.4% | 1.4% | $281.1M | +$7.1M | ||||||||
| MicrosoftCOM · shares +4.9% · price +5.7% | 1.1% | $229.2M | +$11.9M | ||||||||
| Astrazeneca PlcSPONSORED ADR · shares +775% · price −8.8% | 1.0% | $211.9M | −$2.3M | ||||||||
| UberCOM · shares New | 0.98% | $201.0M | — | ||||||||
| Dell Technologies IncCL C · shares +8.6% · price +8.3% | 0.98% | $200.3M | +$14.1M | ||||||||
| SPDR Ser TrPUTS&P BIOTECH · shares New | 0.96% | $197.1M | — | ||||||||
| MicronCOM · shares +99% · price +60.1% | 0.95% | $195.4M | +$36.9M | ||||||||
| Jd.Com IncSPON ADR CL A · shares +23% · price +13.3% | 0.89% | $182.1M | +$17.3M | ||||||||
| Twitter IncCOM · shares +389% · price +21.7% | 0.88% | $180.8M | +$6.6M | ||||||||
| Las Vegas Sands CorpCOM · shares +21% · price +27.7% | 0.88% | $179.7M | +$32.4M | ||||||||
| Capital One Finl CorpCOM · shares +17% · price +37.6% | 0.75% | $153.2M | +$35.9M | ||||||||
| AmazonCOM · shares −70% · price +3.4% | 0.74% | $152.3M | +$5.1M | ||||||||
| Microchip TechnologyCOM · shares +342% · price +34.4% | 0.71% | $145.1M | +$8.4M | ||||||||
| Arch Cap Group LtdORD · shares −19% · price +23.3% | 0.69% | $142.3M | +$26.9M | ||||||||
| T-Mobile Us IncCOM · shares −25% · price +17.9% | 0.69% | $141.4M | +$21.5M | ||||||||
| Eli LillyCOM · shares −36% · price +14.1% | 0.69% | $141.3M | +$17.4M | ||||||||
| Raytheon Technologies CorpCOM · shares −17% · price +24.3% | 0.66% | $135.1M | +$26.4M | ||||||||
| Merck & Co. IncCOM · shares +4.5% · price −1.4% | 0.64% | $132.0M | −$1.8M | ||||||||
| L Brands IncCOM · shares +87% · price +16.9% | 0.62% | $127.6M | +$9.9M | ||||||||
| Five9COM · shares +185% · price +34.5% | 0.62% | $127.0M | +$11.4M | ||||||||
| Autozone IncCOM · shares +171% · price +0.7% | 0.61% | $124.9M | +$303,885 | ||||||||
| Total · 878 positions | 100% | $20.50B | +$1.77B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2020 to Q4 2020: 498 stocks held throughout, up $1.77B (+20.2%).
- Alphabet+$58.5M+20%
- Micron+$36.9M+60%
- Pinterest Inc+$36.4M+59%
- Capital One Finl Corp+$35.9M+38%
- Palo Alto Networks+$34.9M+45%
- Dexcom Inc−$6.4M−10%
- United States Stl Corp New1:29 split−$10.9M−92%
- Apellis Pharmaceuticals Inc1:19 split−$12.1M−90%
- Pacific Biosciences Calif In1:58 split−$21.8M−95%
- Nextera Energy Inc2:1 split−$30.4M−44%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 10 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $90.68B+16% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $78.05B−13% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $89.42B+50% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $59.76B+17% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $50.94B+16% | SEC ↗ |
| Q1 2025 | Jul 21, 2025 (amended) | $43.81B−3% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $45.39B+15% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $39.34B+3% | SEC ↗ |
| Q2 2024 | Sep 16, 2024 (amended) | $38.21B−7% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $41.26B−0% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $41.35B+21% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $34.27B+2% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $33.63B+4% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $32.29B+10% | SEC ↗ |
| Q4 2022 | May 15, 2023 (amended) | $29.42B+18% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $25.04B+6% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $23.70B−6% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $25.19B+1% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $25.04B+10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $22.77B+2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $22.26B+4% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $21.41B+4% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $20.50B+5% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $19.53B+27% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $15.33B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $12.31B−35% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $19.02B+17% | SEC ↗ |
| Q3 2019 | Nov 15, 2019 | $16.28B−15% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $19.11B−13% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $22.03B+8% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $20.48B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $24.25B−3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $25.06B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $23.92B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $23.17B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $22.41B+26% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $17.82B−1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $17.94B+25% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $14.30B+1% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $14.22B−3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $14.70B+13% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $13.04B | SEC ↗ |